NDC 66215-302

Ventavis

Iloprost

Ventavis is a Respiratory (inhalation) Solution in the Human Prescription Drug category. It is labeled and distributed by Actelion Pharmaceuticals Us, Inc.. The primary component is Iloprost.

Product ID66215-302_0b1c1ba9-8e91-4721-9a6d-7795ccbad767
NDC66215-302
Product TypeHuman Prescription Drug
Proprietary NameVentavis
Generic NameIloprost
Dosage FormSolution
Route of AdministrationRESPIRATORY (INHALATION)
Marketing Start Date2005-05-07
Marketing CategoryNDA / NDA
Application NumberNDA021779
Labeler NameActelion Pharmaceuticals US, Inc.
Substance NameILOPROST
Active Ingredient Strength0 mg/mL
Pharm ClassesProstacycline [EPC],Prostaglandins I [CS]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 66215-302-30

30 AMPULE in 1 CARTON (66215-302-30) > 1 mL in 1 AMPULE (66215-302-00)
Marketing Start Date2005-05-07
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 66215-302-00 [66215030200]

Ventavis SOLUTION
Marketing CategoryNDA
Application NumberNDA021779
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2005-05-07

NDC 66215-302-30 [66215030230]

Ventavis SOLUTION
Marketing CategoryNDA
Application NumberNDA021779
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2005-05-07

Drug Details

Active Ingredients

IngredientStrength
ILOPROST.01 mg/mL

OpenFDA Data

SPL SET ID:d3bebc1c-f032-402a-bbc9-aff024276ed1
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 582595
  • 861964
  • 487056
  • 861966
  • Pharmacological Class

    • Prostacycline [EPC]
    • Prostaglandins I [CS]

    NDC Crossover Matching brand name "Ventavis" or generic name "Iloprost"

    NDCBrand NameGeneric Name
    66215-302Ventavisiloprost
    66215-303Ventavisiloprost

    Trademark Results [Ventavis]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    VENTAVIS
    VENTAVIS
    85254212 4028843 Live/Registered
    BAYER INTELLECTUAL PROPERTY GMBH
    2011-03-01
    VENTAVIS
    VENTAVIS
    76209350 2926127 Dead/Cancelled
    BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
    2001-02-13

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.